Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Langer

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Current Problems in Cancer|July 1, 1996
Newer aspects in the diagnosis, treatment, and prevention of non-small cell lung cancer. Part IIC J Langer, E Rosvold
Seminars in Oncology|December 10, 1999
Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancerM A Socinski, C J Langer
Seminars in Oncology|September 5, 1998
Gemcitabine and carboplatin in combination: phase I and phase II studiesC J Langer, P Calvert, R F Ozols
Cancer|October 15, 1992
Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remissionC J Langer, S M Keller, S M Erner
Nutrition (Burbank, Los Angeles County, Calif.)|June 29, 2001
Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexiaC J Langer, J P Hoffman, F D Ottery
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancerE R Sauter, J A Ridge, S Litwin, et al.
The Annals of Thoracic Surgery|April 1, 1993
Postoperative complications after combined neoadjuvant treatment of lung cancerW C Fowler, C J Langer, W J Curran, et al.
Seminars in Oncology|September 5, 1998
An update on North American randomized studies in non-small cell lung cancerP A Bunn, E E Vokes, C J Langer, et al.
Seminars in Oncology|June 1, 1995
Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancerC J Langer, J Leighton, C McAleer, et al.
Pharmacotherapy|March 1, 1996
Acute encephalopathy attributed to 5-FUC J Langer, A Hageboutros, D D Kloth, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Current Problems in Cancer|July 1, 1996
Newer aspects in the diagnosis, treatment, and prevention of non-small cell lung cancer. Part IIC J Langer, E Rosvold
Seminars in Oncology|December 10, 1999
Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancerM A Socinski, C J Langer
Seminars in Oncology|September 5, 1998
Gemcitabine and carboplatin in combination: phase I and phase II studiesC J Langer, P Calvert, R F Ozols
Cancer|October 15, 1992
Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remissionC J Langer, S M Keller, S M Erner
Nutrition (Burbank, Los Angeles County, Calif.)|June 29, 2001
Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexiaC J Langer, J P Hoffman, F D Ottery
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Pretreatment p53 protein expression correlates with decreased survival in patients with end-stage head and neck cancerE R Sauter, J A Ridge, S Litwin, et al.
The Annals of Thoracic Surgery|April 1, 1993
Postoperative complications after combined neoadjuvant treatment of lung cancerW C Fowler, C J Langer, W J Curran, et al.
Seminars in Oncology|September 5, 1998
An update on North American randomized studies in non-small cell lung cancerP A Bunn, E E Vokes, C J Langer, et al.
Seminars in Oncology|June 1, 1995
Paclitaxel and carboplatin in the treatment of advanced non-small cell lung cancerC J Langer, J Leighton, C McAleer, et al.
Pharmacotherapy|March 1, 1996
Acute encephalopathy attributed to 5-FUC J Langer, A Hageboutros, D D Kloth, et al.
Pageof 5